Login / Signup

Clarithromycin Versus Metronidazole in First-Line Helicobacter Pylori Triple Eradication Therapy Based on Resistance to Antimicrobial Agents: Meta-Analysis.

Masaki MurataMitsushige SugimotoHitomi MizunoTakeshi KannoKiichi Satoh
Published in: Journal of clinical medicine (2020)
Overall eradication rates with PAC and PAM were equivalent worldwide. In low MNZ-resistance areas, PAM may be recommended as first-line therapy. However, the efficacy of PAC may be insufficient, irrespective of susceptibility to CAM.
Keyphrases
  • helicobacter pylori
  • helicobacter pylori infection
  • systematic review
  • staphylococcus aureus
  • stem cells
  • randomized controlled trial
  • replacement therapy